Vanguard Capital Management’s Cardio Diagnostics CDIO Stock Holding History
Bought
Maintained
Sold
Other funds holding CDIO
Vanguard Capital Management's CDIO Position: Q3 2026 in Review
Vanguard Capital Management held its Cardio Diagnostics (CDIO) position steady in Q3 2026 at 20,155 shares worth $38.3K. The position accounts for ﹤0.01% of the portfolio, ranked #3933.
Vanguard Capital Management first reported a position in CDIO in Q1 2026 and has held it in 3 quarters since. The position peaked at $44.1K in Q2 2026. 13 funds tracked by Wall St. Rank hold CDIO as of Q3 2026.
- Vanguard Capital Management held 20,155 shares of Cardio Diagnostics worth $38.3K as of Q3 2026.
- Vanguard Capital Management left its Cardio Diagnostics share count unchanged in Q3 2026.
- Cardio Diagnostics made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #3933 holding.
- Vanguard Capital Management first reported a position in Cardio Diagnostics in Q1 2026 and has held it in 3 quarters since.
- Vanguard Capital Management's Cardio Diagnostics position peaked at $44.1K in Q2 2026.
- 13 funds tracked by Wall St. Rank held Cardio Diagnostics as of Q3 2026.
Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.